{"brief_title": "Infusion Laboratory: Protocol 2 (Lisuride) - 3", "brief_summary": "The purpose of this study is to evaluate clinical safety issues pertaining to lisuride, to cocaine, and to its interaction in a chronic, crack dependent population, and to determine how pretreatment with lisuride modifies the subjective as well as physiological effects of cocaine.", "condition": ["Cocaine-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Lisuride"], "criteria": "Inclusion Criteria: M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "50 Years", "healthy_volunteers": "No", "keyword": "cocaine dependence", "mesh_term": ["Cocaine-Related Disorders", "Lisuride"], "id": "NCT00000338"}